Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/SHK.0000000000001635 http://scihub22266oqcxt.onion/10.1097/SHK.0000000000001635 32769822!8858425!32769822     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Shock 2021 ; 55 (3): 316-320 Nephropedia Template TP {{tp|p=32769822|t=2021. Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU |pdf=|usr=}}{{32769822}} gab.com Text Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU JO: Shock http://www.kidney.de/pget.php?&tw=1&pmid=32769822 #FOAvip The coronavirus disease (COVID-19) pandemic has threatened millions of lives worldwide with severe systemic inflammation, organ dysfunction, and thromboembolic disease. Within our institution, many critically ill COVID-19-positive patients suffered major thrombotic events, prompting our clinicians to evaluate hypercoagulability outside of traditional coagulation testing.We determined the prevalence of fibrinolysis shutdown via rotational thromboelastometry (ROTEM, Instrumentation Laboratories, Bedford, Mass) in patients admitted to the intensive care unit over a period of 3 weeks. In 25 patients who had a ROTEM test, we found that 11 (44%) met criteria for fibrinolysis shutdown. Eight of 9 (73%) of the VTE patients met criteria for fibrinolysis shutdown.Given the high rate of fibrinolysis shutdown in these patients, our data support using viscoelastic testing to evaluate for the presence of impaired fibrinolysis. This may help identify patient subsets who might benefit from the administration of fibrinolytics. Twit Text FOAVip Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU ????Shock http://www.kidney.de/pget.php?&tw=1&pmid=32769822 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32769822 #FOAvip English Wikipedia <ref>{{Cite pmid|32769822}}</ref> Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU #MMPMID32769822 Creel-Bulos C; Auld SC; Caridi-Scheible M; Barker NA; Friend S; Gaddh M; Kempton CL; Maier CL; Nahab F; Sniecinski R Shock 2021[Mar]; 55 (3): 316-320 PMID32769822show ga The coronavirus disease (COVID-19) pandemic has threatened millions of lives worldwide with severe systemic inflammation, organ dysfunction, and thromboembolic disease. Within our institution, many critically ill COVID-19-positive patients suffered major thrombotic events, prompting our clinicians to evaluate hypercoagulability outside of traditional coagulation testing.We determined the prevalence of fibrinolysis shutdown via rotational thromboelastometry (ROTEM, Instrumentation Laboratories, Bedford, Mass) in patients admitted to the intensive care unit over a period of 3 weeks. In 25 patients who had a ROTEM test, we found that 11 (44%) met criteria for fibrinolysis shutdown. Eight of 9 (73%) of the VTE patients met criteria for fibrinolysis shutdown.Given the high rate of fibrinolysis shutdown in these patients, our data support using viscoelastic testing to evaluate for the presence of impaired fibrinolysis. This may help identify patient subsets who might benefit from the administration of fibrinolytics. |*Fibrinolysis/drug effects[MESH] |*Intensive Care Units[MESH] |*Thrombelastography[MESH] |Adult[MESH] |Aged[MESH] |COVID-19/blood/*complications/diagnosis[MESH] |Clinical Decision-Making[MESH] |Female[MESH] |Fibrinolytic Agents/therapeutic use[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Patient Selection[MESH] |Predictive Value of Tests[MESH] |Retrospective Studies[MESH] |Thrombophilia/blood/*diagnosis/drug therapy/etiology[MESH] |Thrombosis/blood/*diagnosis/drug therapy/etiology[MESH]Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU (epmc).pdf DeepDyve Pubget Overpricing